2022
DOI: 10.1007/s11042-022-12229-z
|View full text |Cite
|
Sign up to set email alerts
|

Classification of malignant tumors by a non-sequential recurrent ensemble of deep neural network model

Abstract: Many significant efforts have so far been made to classify malignant tumors by using various machine learning methods. Most of the studies have considered a particular tumor genre categorized according to its originating organ. This has enriched the domainspecific knowledge of malignant tumor prediction, we are devoid of an efficient model that may predict the stages of tumors irrespective of their origin. Thus, there is ample opportunity to study if a heterogeneous collection of tumor images can be classified… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 64 publications
0
1
0
Order By: Relevance
“…In medical science, artificial intelligence has been used for classifying malignant tumours by a non-sequential recurrent ensemble of the deep neural network model. The training and validation accuracy and the ROC-AUC scores have been satisfactory over the existing models [ 38 ]. In medical science, artificial intelligence has been used for classifying malignant tumours by a non-sequential recurrent ensemble of the deep neural network model.…”
Section: Introductionmentioning
confidence: 99%
“…In medical science, artificial intelligence has been used for classifying malignant tumours by a non-sequential recurrent ensemble of the deep neural network model. The training and validation accuracy and the ROC-AUC scores have been satisfactory over the existing models [ 38 ]. In medical science, artificial intelligence has been used for classifying malignant tumours by a non-sequential recurrent ensemble of the deep neural network model.…”
Section: Introductionmentioning
confidence: 99%